(Q45415175)

14 December 2017

title

Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease (English)

1 reference

14 December 2017

1 reference

13

Adrian Covic

1 reference

14 December 2017

2

1 reference

14 December 2017

Irina-Luanda Mititiuc

12

object named as

Irina Mititiuc

1 reference

14 December 2017

6

Tayfun Eyileten

1 reference

14 December 2017

10

Sebahattin Sari

1 reference

14 December 2017

14

Mehmet Kanbay

1 reference

14 December 2017

Mahmut I Yilmaz

1

1 reference

14 December 2017

Mutlu Saglam

3

1 reference

14 December 2017

Yasemin G Kurt

4

1 reference

14 December 2017

Hilmi U Unal

5

1 reference

14 December 2017

Mahmut Gok

7

1 reference

14 December 2017

Hakki Cetinkaya

8

1 reference

14 December 2017

Yusuf Oguz

9

1 reference

14 December 2017

Abdulgaffar Vural

11

1 reference

14 December 2017

language of work or name

English

0 references

publication date

2 July 2014

1 reference

14 December 2017

1 reference

14 December 2017

volume

86

1 reference

14 December 2017

issue

6

1 reference

14 December 2017

page(s)

1213-1220

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2014.227

14 December 2017

exact match

0 references

cites work

Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Chronic kidney disease as cause of cardiovascular morbidity and mortality

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Endocan, a new endothelial marker in human sepsis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Endocan expression and relationship with survival in human non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Endocan expression and localization in human glioblastomas

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1α in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Expression and distribution of endocan in human tissues

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Getting to the site of inflammation: the leukocyte adhesion cascade updated

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

NFκB in the development of endothelial activation and damage in uremia: an in vitro approach

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Vascular endocan is preferentially expressed in tumor endothelium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Prognostic value of brachial artery endothelial function and wall thickness

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Carotid-wall intima-media thickness and cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Carotid intima media thickness predicts cardiovascular diseases in Chinese predialysis patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Insulin Resistance, Inflammation, and Vascular Disease in Nondiabetic Predialysis Chronic Kidney Disease Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease – a cross-sectional study of predialysis, dialysis and kidney-transplantation patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Increased resistin in brain dead organ donors is associated with delayed graft function after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

The role of resistin as a regulator of inflammation: Implications for various human pathologies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

The contribution of adhesion molecule expression in donor kidney biopsies to early allograft dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

New insights on inflammation in chronic kidney disease-genetic and non-genetic factors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Serum endocan levels as a marker of disease activity in patients with Behçet disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.227

7 January 2021

Identifiers

DOI

10.1038/KI.2014.227

1 reference

Dimensions Publication ID

14 December 2017

1032866282

0 references

1 reference